Gilead Sciences Inc said it won United States approval from Food and Drug Administration regulators for a drug to prevent HIV that only has to be given twice a year. That makes it a convenient new way ...

At an event in the Indian capital marking Bangladesh’s belated “Independence Day celebration,” Bangladesh’s envoy called for reimagining apparent “frosty ties.” ...

The arrest of 11 Iranian nationals comes as the U.S. is on high alert for possible retaliatory attacks and sleeper cells.

Recent data from the University of Maryland show the tropics lost 6.7 million hectares (16.6 million acres) of primary ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...

The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able to outpace the damage?

The health concerns surrounding endocrine disruptors, such as phthalates, BPA and PFAS, can sound scary. But what we do know ...

On the eve of the International Day Against Drug Abuse and Illicit Trafficking, China released the "China Drug Situation in ...